Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-01-23

Clinical Trial Update: Hepatocyte Transplantation for Acute Decompensated Liver Failure [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating hepatocyte transplantation for acute decompensated liver failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hepatocyte transplantation (hepatocytes)

Snippet

Sponsor: Ira Fox | Conditions: Liver Failure Acute | Phase 1 | Status: WITHDRAWN